Asthma a chronic respiratory condition may be driven by specific immune cells that influence inflammation and severity ...

New research suggests that elevated circulating cAMP levels could serve as a potential biomarker for asthma. Read more.

Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.

BOULDER, Colo.--(BUSINESS WIRE)--#AI--Enveda, a biotechnology company using AI to translate nature into new medicines, is proud to announce testing of its lead asset, ENV-294, in a second indication: ...

The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier ...

Background It remains unknown whether child-oriented asthma education is associated with better health outcomes. This meta-analysis investigated the effects of asthma education on hospitalisation and ...

Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of ...

While factors such as myocardial ischaemia, worsening renal function, volume overload and chronic pulmonary disease may contribute to decompensation, the primary pathophysiology in hypertensive AHF ...

There’s a chance people with asthma may have a bad reaction to nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. You can talk with your doctor about other options, including Tylenol.

FGF receptors (FGFRs) are involved in the pathogenesis of cancer and skeletal disorders. Experiments in model systems have shown that FGFR-specific inhibitors may be valuable in treating multiple ...